LGG
Clinical trials for LGG explained in plain language.
Never miss a new study
Get alerted when new LGG trials appear
Sign up with your email to follow new studies for LGG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo targets tough cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new oral drug (PF-07799544) alone or with another drug for adults with advanced solid tumors that have a BRAF V600 mutation, including melanoma, lung, thyroid, and brain cancers. The goal is to check safety and how well the drugs work. About 124 par…
Matched conditions: LGG
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
New hope for hard-to-treat BRAF cancers: drug targets tumor drivers
Disease control Recruiting nowThis study tests a drug called FORE8394 (plixorafenib) in people aged 10 and older whose cancers have specific BRAF gene changes. The goal is to see if the drug can shrink tumors or slow their growth. About 254 participants with advanced solid tumors or brain tumors will take the…
Matched conditions: LGG
Phase: PHASE2 • Sponsor: Fore Biotherapeutics • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC